ArticleNeoplasia (New York, N.Y.)2010

An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo.

Shafaat A Rabbani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.